These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12628080)

  • 21. Treatment modalities of obesity: what fits whom?
    Hainer V; Toplak H; Mitrakou A
    Diabetes Care; 2008 Feb; 31 Suppl 2():S269-77. PubMed ID: 18227496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction.
    Lee M; Aronne LJ
    Am J Cardiol; 2007 Feb; 99(4A):68B-79B. PubMed ID: 17307059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of adiposity as a determinant of an inflammatory milieu.
    Calabrò P; Limongelli G; Pacileo G; Di Salvo G; Golino P; Calabrò R
    J Cardiovasc Med (Hagerstown); 2008 May; 9(5):450-60. PubMed ID: 18403996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity. Pathogenesis, consequences, and approaches to treatment.
    Weiss SR
    Psychiatr Clin North Am; 1984 Jun; 7(2):307-19. PubMed ID: 6473186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to evaluate and treat obesity.
    Minnesota Medical Association Obesity Task Force
    Minn Med; 2005 Sep; 88(9):40-6. PubMed ID: 16475412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular implications of obesity.
    Nichols N
    Can J Cardiovasc Nurs; 2006; 16(2):58-63. PubMed ID: 17153133
    [No Abstract]   [Full Text] [Related]  

  • 27. Obesity pharmacotherapy from a regulatory perspective: overview and key challenges.
    Hutchinson NI; Ryder SW
    Clin Pharmacol Ther; 2007 May; 81(5):756-60. PubMed ID: 17392723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Leptin--adipose tissue hormone and its role in cardiovascular diseases].
    Racek-Król B
    Pol Merkur Lekarski; 2006 Jun; 20(120):713-6. PubMed ID: 17007277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The childhood obesity epidemic: impact on endothelial function.
    Gielen S; Hambrecht R
    Circulation; 2004 Apr; 109(16):1911-3. PubMed ID: 15117859
    [No Abstract]   [Full Text] [Related]  

  • 30. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women.
    Engelson ES; Agin D; Kenya S; Werber-Zion G; Luty B; Albu JB; Kotler DP
    Metabolism; 2006 Oct; 55(10):1327-36. PubMed ID: 16979403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
    Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
    Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Untangling the heavy cardiovascular burden of obesity.
    Lavie CJ; Milani RV; Ventura HO
    Nat Clin Pract Cardiovasc Med; 2008 Jul; 5(7):428-9. PubMed ID: 18521107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular basis of obesity and the risk for cardiovascular disease.
    Soufi M; Sattler AM; Herzum M; Maisch B; Schaefer JR
    Herz; 2006 May; 31(3):200-6. PubMed ID: 16770555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary therapy in polycystic ovary syndrome.
    Moran LJ; Brinkworth GD; Norman RJ
    Semin Reprod Med; 2008 Jan; 26(1):85-92. PubMed ID: 18181086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives.
    Gualillo O; González-Juanatey JR; Lago F
    Trends Cardiovasc Med; 2007 Nov; 17(8):275-83. PubMed ID: 18021938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term weight loss decreases the nontraditional cardiovascular risk factors interleukin-18 and matrix metalloproteinase-9 in obese subjects.
    Madsen EL; Bruun JM; Skogstrand K; Hougaard DM; Christiansen T; Richelsen B
    Metabolism; 2009 Jul; 58(7):946-53. PubMed ID: 19409578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of leptin in reverse epidemiology in chronic kidney disease.
    Scholze A; Tepel M
    Semin Dial; 2007; 20(6):534-8. PubMed ID: 17991200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity-hypertension: an ongoing pandemic.
    Francischetti EA; Genelhu VA
    Int J Clin Pract; 2007 Feb; 61(2):269-80. PubMed ID: 17263714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adipose tissue, insulin resistance and low-grade inflammation: implications for atherogenesis and the cardiovascular harm of estrogen plus progestogen therapy.
    Tankó LB; Christiansen C
    Climacteric; 2006 Jun; 9(3):169-80. PubMed ID: 16766431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survey of cardiovascular risk factors in overweight and obese patients (SCOOP study) six-month changes in risk factor levels and cardiovascular risk.
    Iori I; Fatati G; Fusco MA; Leonardi F; Matthieu G; Scanelli G; Lanti M; Menotti A
    Eur J Intern Med; 2009 May; 20(3):280-8. PubMed ID: 19393495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.